- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/745 - Blood coagulation or fibrinolysis factors
Patent holdings for IPC class C07K 14/745
Total number of patents in this class: 704
10-year publication summary
|
54
|
57
|
51
|
59
|
58
|
53
|
58
|
26
|
28
|
12
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2961 |
29 |
| Bioverativ Therapeutics Inc. | 220 |
21 |
| The Children's Hospital of Philadelphia | 716 |
17 |
| Novo Nordisk Health Care AG | 342 |
16 |
| HCW Biologics, Inc. | 56 |
16 |
| Modernatx, Inc. | 1181 |
14 |
| Opko Biologics Ltd. | 75 |
13 |
| CSL Behring GmbH | 350 |
11 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 306 |
11 |
| The University of North Carolina at Chapel Hill | 1928 |
11 |
| Yale University | 2204 |
11 |
| Gladiator Biosciences, Inc. | 15 |
11 |
| CSL Limited | 251 |
10 |
| Alexion Pharmaceuticals, Inc. | 606 |
8 |
| Case Western Reserve University | 1727 |
8 |
| Novo Nordisk Healthcare AG | 35 |
8 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
7 |
| The Scripps Research Institute | 1364 |
7 |
| Baxter International Inc. | 2425 |
6 |
| Baxter Healthcare S.A. | 1810 |
6 |
| Other owners | 463 |